Exact Therapeutics AS (OSL:EXTX) Total Assets: kr67.40 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

OSL:EXTX Exact Therapeutics AS OSL:EXTX
21 GF Score
Price kr0.73
! 2 Warning Signs
View Full Analysis

What is Exact Therapeutics AS Total Assets?

Exact Therapeutics AS OSL:EXTX +0.69% 21 Total Assets is kr67.40 Mil as of Dec. 2025. GuruFocus rates OSL:EXTX with a GF Score™ of 21/100. The stock has 2 warning signs investors should review.

Exact Therapeutics AS's Total Assets for the quarter that ended in Dec. 2025 was kr67.40 Mil.

During the past 12 months, Exact Therapeutics AS's average Total Assets Growth Rate was -20.40% per year. During the past 3 years, the average Total Assets Growth Rate was 46.40% per year. During the past 5 years, the average Total Assets Growth Rate was 37.60% per year.

During the past 9 years, Exact Therapeutics AS's highest 3-Year average Total Assets Growth Rate was 56.50%. The lowest was 13.30%. And the median was 38.40%.

Total Assets is connected with ROA %. Exact Therapeutics AS's annualized ROA % for the quarter that ended in Dec. 2025 was -89.60%. Total Assets is also linked to Revenue through Asset Turnover. Exact Therapeutics AS's Asset Turnover for the quarter that ended in Dec. 2025 was 0.00.

Exact Therapeutics AS  (OSL:EXTX) Total Assets Explanation

Total Assets is connected with ROA %.

Exact Therapeutics AS's annualized ROA % for the quarter that ended in Dec. 2025 is

ROA %=Net Income (Q: Dec. 2025 )/( (Total Assets (Q: Jun. 2025 )+Total Assets (Q: Dec. 2025 ))/ count )
=-75.59/( (101.341+67.396)/ 2 )
=-75.59/84.3685
=-89.60 %

Note: The Net Income data used here is two times the semi-annual (Dec. 2025) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Exact Therapeutics AS's Asset Turnover for the quarter that ended in Dec. 2025 is

Asset Turnover
=Revenue (Q: Dec. 2025 )/( (Total Assets (Q: Jun. 2025 )+Total Assets (Q: Dec. 2025 ))/ count )
=0/( (101.341+67.396)/ 2 )
=0/84.3685
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Exact Therapeutics AS Total Assets Related Terms

Exact Therapeutics AS Total Assets Historical Data

* Premium members only.

The historical data trend for Exact Therapeutics AS's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Exact Therapeutics AS Total Assets Chart

Exact Therapeutics AS Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Assets
Get a 7-Day Free Trial Premium Member Only 117.63 82.51 61.32 153.20 67.40

Exact Therapeutics AS Semi-Annual Data
Dec17 Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Total Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 61.32 31.36 153.20 101.34 67.40
OSL:EXTX
21GF Score
Exact Therapeutics AS OSL:EXTX
Total Assets is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Exact Therapeutics AS Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Exact Therapeutics AS's Total Assets for the fiscal year that ended in Dec. 2025 is calculated as

Total Assets=Total Equity (A: Dec. 2025 )+Total Liabilities (A: Dec. 2025 )
=30.708+36.689
=67.40

Exact Therapeutics AS's Total Assets for the quarter that ended in Dec. 2025 is calculated as

Total Assets=Total Equity (Q: Dec. 2025 )+Total Liabilities (Q: Dec. 2025 )
=30.708+36.689
=67.40

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Assets →
What does a Total Assets of kr67.40 Mil mean?
Exact Therapeutics AS (OSL:EXTX) has a Total Assets of kr67.40 Mil as of Dec. 2025. The total amount of assets as recorded on a company's balance sheet. View historical data on Exact Therapeutics AS and its competitors.
Is Exact Therapeutics AS's Total Assets too high?
Exact Therapeutics AS's current Total Assets is kr67.40 Mil. Overall, Exact Therapeutics AS has a GF Score™ of 21/100, reflecting its overall financial health beyond just this single metric.
How does Exact Therapeutics AS's Total Assets compare to VRTX and REGN?
Exact Therapeutics AS's Total Assets of kr67.40 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Assets for a Biotechnology company?
A good Total Assets depends on the Biotechnology industry context. However, Total Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Assets mean?
A high Total Assets can signal that a stock is expensive relative to its fundamentals. The total amount of assets as recorded on a company's balance sheet. View historical data on Exact Therapeutics AS and its competitors. Exact Therapeutics AS's current Total Assets is kr67.40 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Exact Therapeutics AS stock overvalued right now?
Exact Therapeutics AS (OSL:EXTX) has a current Total Assets of kr67.40 Mil. The current Total Assets is kr67.40 Mil. Exact Therapeutics AS's overall GF Score™ is 21/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Assets calculated?
Total Assets is calculated from a company's financial statements. For Exact Therapeutics AS (OSL:EXTX), the current Total Assets is kr67.40 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Exact Therapeutics AS Business Description

Address Ostre Aker Vei 19, Oslo, NOR, 0581
Exact Therapeutics AS is a clinical-stage biotechnology company focused on developing Acoustic Cluster Therapy (ACT), a non-invasive ultrasound-mediated technology for targeted enhancement of therapeutic agents. Its ACT platform (PS101) is being evaluated mainly in oncology, including pancreatic cancer and liver metastases, with additional applications in immuno-oncology, gene therapy, and central nervous system disorders.
21GF Score

Get the complete analysis for OSL:EXTX

Total Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr0.73
Price